Summary#

SB 26-161, the Cannabis Consumer Protection Act, would amend existing Colorado laws on cannabis taxes, licensing and product safety, and add new registration and testing rules. Its stated goal is to improve consumer protection and make cannabis taxes reflect the amount of intoxicating cannabinoids in products; those are goals, not guaranteed results. The bill failed, so it did not change the law.

• Starting January 1, 2027, it would replace the 15% state retail marijuana sales tax with a tax based on milligrams of intoxicating cannabinoids. The listed rates are 1.2 cents per milligram for edible products and 0.4 cents for other listed product types.
• It would replace the 15% tax on the first transfer of unprocessed marijuana with an inflation-adjusted tax of $1 per pound.
• It would move product testing and safety oversight from the Department of Revenue to the Department of Public Health and Environment (DPHE). Revenue would retain licensing and tax-compliance roles.
• DPHE would have to register businesses that produce intoxicating cannabis products, establish a state reference laboratory by January 1, 2027, and run retail-level product surveillance testing. The contaminant-testing part must be in place by January 1, 2030.
• The bill would require public access to adverse health reports, product test results and traceability information, with some personal information redacted. It would allow penalties and product actions for violations, including quarantine, relabeling, destruction or recall.

What it means for you#

• Consumers: If the bill had taken effect, the state cannabis sales tax would have depended on a product’s intoxicating-cannabinoid content rather than its sale price. Other state and local sales taxes would still apply. The bill sets maximum rates of 2 cents per milligram before January 1, 2030, and 5 cents from that date, but the tax rates could be changed by later legislation.
• Consumers: You could have accessed product testing and traceability information online. Members of the public legally allowed to buy a product could also request testing for a fee.
• Cannabis producers and other regulated businesses: Producers would have needed DPHE registration and would have paid fees set to cover the costs of processing applications and carrying out the new rules. Licensed businesses would have had to obtain product testing when products were packaged for sale or distribution to consumers. The bill also allows DPHE to test products at any point in the supply chain.
• Businesses with violations: DPHE could order product actions and impose civil penalties. The bill also allows referral to the state licensing authority for a corrective-action plan and at least 30 days of probation, or a license suspension of 30 to 365 days.
• The public: The bill would have changed agency responsibilities and created testing and registration requirements; it did not establish a new independent regulator.

Money#

No cost estimate or expected overall revenue change is included in the supplied material; no publicly available information.

• Cannabis producers would have paid registration fees set to cover DPHE’s direct and indirect costs. Licensed businesses could also be charged for required testing.
• The state tax on retail products would have shifted from a percentage of the sale price to rates based on cannabinoid content. The bill does not establish whether this would raise or reduce total tax revenue.
• Legislative Council Staff would have had to project revenue and could propose tax-rate adjustments. Those adjustments would not happen automatically: the Joint Budget Committee could introduce legislation, which would need to become law.
• Public testing could carry a fee. The bill does not give a fee amount or total staffing and laboratory cost.

What is unclear#

• The supplied bill text ends partway through a section on penalties, so the rest of the bill’s provisions cannot be verified from the material provided.
• The bill leaves many testing details to rules, including sampling frequency and how allowable differences between labels and test results would be set.
• The term “intoxicating cannabinoid” refers partly to chemicals listed in another law not included here, so the full scope of products covered could not be checked.
• The bill does not say how the new duties would be staffed or how DPHE and the licensing authority would coordinate in every case.
• The exact effect of the new tax on the price of particular products is unclear; it would depend on product content and price.

Case for#

• The bill appears intended to address health and consumer-safety risks from products with different potencies and production methods by placing safety oversight with a public-health agency.
• Testing products packaged for consumers, publishing results and checking products on retail shelves could give consumers more information and help identify unsafe or inaccurately labelled products.
• A tax tied to cannabinoid content could be seen as a way to tax products according to their intoxicating content rather than their sale price.

Case against#

• Required testing, registration fees and possible penalties could add costs for regulated businesses; the bill provides no total cost estimate.
• The bill sets important testing and enforcement details through future rules, so businesses and consumers could not tell from the bill alone exactly how the system would work.
• The tax shift could change the tax paid on different products, but the bill does not establish the overall revenue effect or how individual prices would change.